Thy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes.

by Geoffrey O Gillard, Maytal Bivas-Benita, Avi-Hai Hovav, Lauren E Grandpre, Michael W Panas, Michael S Seaman, Barton F Haynes, Norman L Letvin
Published 2011-08-01

Correction: Thy1 Nk Cells from Vaccinia Virus-Primed Mice Confer Protection against Vaccinia Virus Challenge in the Absence of Adaptive Lymphocytes.

by Geoffrey O. Gillard, Maytal Bivas-Benita, Avi-Hai Hovav, Lauren E. Grandpre, Michael W. Panas, Michael S. Seaman, Barton F. Haynes, Norman L. Letvin
Published 2011-08-01

Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells.

by Manjunatha M Venkataswamy, Tony W Ng, Shalu S Kharkwal, Leandro J Carreño, Alison J Johnson, Shajo Kunnath-Velayudhan, Zheng Liu, Robert Bittman, Peter J Jervis, Liam R Cox, Gurdyal S Besra, Xiangshu Wen, Weiming Yuan, Moriya Tsuji, Xiangming Li, David D Ho, John Chan, Sunhee Lee, Richard Frothingham, Barton F Haynes, Michael W Panas, Geoffrey O Gillard, Jaimie D Sixsmith, Birgit Korioth-Schmitz, Joern E Schmitz, Michelle H Larsen, William R Jacobs, Steven A Porcelli
Published 2014-01-01